Great Piece on Critical Decisions
Here is a well-written piece by The Global Mail discussing Critical Decisions. Take a look.
In my previous post, I showed a powerful picture (from the Kaiser Family Foundation) of the growth in high deductible insurance plans. Here is another picture from that same report, showing that the high end of these high ends is getting really high. (Click here to view comments)
I had the great pleasure of speaking with Tess Vigeland, host of Marketplace Money. We discussed my book Critical Decisions in the context of what shared decision making means about patients paying attention to the cost of their medical care. Listen to the whole segment, because she is a great interviewer. And find out why…
Chemotherapy drugs have become ridiculously expensive. Many new drugs come to market costing more than $100,000 per patient for a full course of treatment. Often, patients have to pay a significant portion of these costs. For example, a 20% co-insurance rate, typical for basic Medicare coverage, leaves patients responsible for more than $20,000 of chemotherapy costs,…
A review of Critical Decisions was recently published in The American Journal of Bioethics. You can check it out here. (Click here to view comments)
My colleagues and I have been doing lots of research lately on how physicians and patients discuss out-of-pocket expenses during clinic encounters. One of our recent publications has been getting lots of attention, with this being the latest example. I thought I would share it with you: Recent qualitative findings published in Health Affairs showed that physicians…
JoAnn Pushkin’s breast cancer was diagnosed at an advanced stage because the density of her breasts obscured the tumor on her mammograms. That was shocking news to Pushkin, who only learned that her breasts were radiologically dense at the time of her diagnosis. Activated by this revelation, she has become a leading advocate of legislation,…